Skip to main content
. 2014 Jul 22;34(7):813–819. doi: 10.1007/s10875-014-0081-9

Fig. 3.

Fig. 3

Immunological phenotype of patients treated at different Ig administration intervals. (a) IgA serum levels; (b) percentages of peripheral blood switched B memory B cells (CD19 + CD27 + IgM-IgD-) in PAD patients grouped according to the replacement intervals of IVIG administration: 1-week, 2-weeks, 3-weeks, 4-weeks. Statistical differences between groups are shown